Defensin beta 115 (DEFB115)

Defensin beta 115 (DEFB115) is a small, cysteine-rich, cationic peptide that belongs to the beta-defensin subfamily and is part of the innate immune system[4][1][2]. Like other beta-defensins, DEFB115 is believed to be mainly expressed in epithelial tissues, particularly in the male reproductive tract[1][3]. Beta-defensins are active against a broad range of pathogens by disrupting microbial membranes through pore formation and membrane depolarization, and they also participate in immune cell regulation via chemotaxis and cytokine signaling[1][2][3]. While several beta-defensins are well-studied for their antimicrobial properties and roles in mucosal immunity, direct data on DEFB115's unique function or disease association are limited[4]. DEFB115 is not currently regarded as a druggable therapeutic target, nor are there known drug interactions, mechanisms of action for pharmacological agents, or established uses as a clinical biomarker[4]. This molecule is a legitimate gene/protein entity, not an error or artifact, but it is not commonly targeted by drugs, nor is there significant literature about it as a clinical or pharmacological target[4][1]. If more detailed functional or expression data are needed for DEFB115 specifically, sources suggest that, like other beta-defensins, its primary role is presumed to be antimicrobial defense and local immune modulation in epithelial tissues, potentially with a more specific function in the male reproductive tract[1][3][4].

Other names

Beta-defensin 115DEFB15DEFB-15Beta-defensin 15Defensin, beta 115beta-defensin 115beta-defensin 15defensin, beta 15

Not applicable (no drugs or inhibitors known; acts as a naturally produced antimicrobial and immune-modulating peptide)